CAVA Group
CAVA
52.07
-0.57
-1.08%
CAVA Group
US · CAVA
#1881 by market cap
Listed 2023
52.07
-0.57
-1.08%
Live - 5344 symbols - heartbeat 456s ago
· 2026-10-08 06:33
Pre-market
52.69
+1.19%
After-hours
52.13
+0.12%
Overnight
52.00
-0.13%
- Market cap
- 6.08B
- P/E (TTM)i
- 92.98
- P/Bi
- 7.23
- EPSi
- 0.54
- Div yieldi
- 0.00%
- 52W posi
- 16%
Reader sentiment
Are you bullish or bearish on CAVA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.32, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 5 years
Latest year +22.41% YoY
Margins
- Gross margin
- 24.62%
- Operating margin
- 6.73%
- Net margin
- 5.40%
Key ratios & quality
- Altman Z-Scorei
- 7.32
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 500.07M | 564.12M | 728.70M | 963.71M | 1.18B |
| Gross profit | 82.15M | 97.98M | 180.35M | 241.81M | 290.47M |
| Selling & admin expenses | 64.79M | 70.04M | 101.49M | 120.50M | 137.46M |
| Research & development | -- | -- | -- | -- | -- |
| Operating profit | -27.18M | -14.78M | 31.42M | 60.95M | 79.34M |
| Pretax profit | -37.27M | -58.89M | 14.05M | 59.91M | 70.80M |
| Tax | 117.00K | 93.00K | 768.00K | -70.41M | 7.06M |
| Net profit | -37.39M | -58.99M | 13.28M | 130.32M | 63.74M |
| Basic EPS | 0 | -1 | 0 | 1 | 1 |
| Diluted EPS | -0.39 | -0.61 | 0.21 | 1.10 | 0.54 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 331.83M | 280.62M | 292.24M | 274.99M | 438.27M | 368.44M |
| Gross profit | 84.06M | 74.68M | 72.37M | 59.36M | 111.19M | 95.58M |
| Selling & admin expenses | 41.39M | 32.05M | 31.50M | 32.52M | 51.59M | 39.80M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 21.86M | 25.82M | 23.24M | 8.43M | 34.14M | 34.82M |
| Pretax profit | 20.35M | 23.70M | 20.67M | 6.08M | 30.04M | 30.58M |
| Tax | -5.35M | 5.33M | 5.92M | 1.16M | 6.47M | 7.56M |
| Net profit | 25.71M | 18.37M | 14.75M | 4.92M | 23.57M | 23.02M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.22 | 0.16 | 0.12 | 0.04 | 0.20 | 0.19 |
Balance sheet
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total current assets | 154.39M | 58.15M | 354.91M | 394.15M | 431.07M |
| Cash & ST investments | 140.33M | 39.13M | 332.43M | 366.12M | 393.03M |
| Inventory | 3.64M | 5.14M | 5.64M | 7.60M | 9.02M |
| Total assets | 362.20M | 583.88M | 983.76M | 1.17B | 1.36B |
| Total current liabilities | 51.73M | 84.32M | 109.04M | 132.64M | 162.66M |
| Short-term debt | -- | 29.54M | 32.58M | 37.24M | 48.53M |
| Long-term debt | -- | -- | -- | -- | -- |
| Total liabilities | 755,216,000.00 | 1,032,386,000.00 | 412,955,000.00 | 474,103,000.00 | 580,371,000.00 |
| Total equity | -393.02M | -448.50M | 570.80M | 695.57M | 779.66M |
| Retained earnings | -402.53M | -460.94M | -447.66M | -317.34M | -253.60M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 403.03M | 418.54M | 425.13M | 431.07M | 444.70M | 479.87M |
| Cash & ST investments | 369.27M | 385.78M | 387.69M | 393.03M | 402.96M | 435.60M |
| Inventory | 7.28M | 7.99M | 8.58M | 9.02M | 9.26M | 9.80M |
| Total assets | 1.23B | 1.29B | 1.32B | 1.36B | 1.42B | 1.50B |
| Total current liabilities | 134.28M | 153.71M | 158.29M | 162.66M | 167.52M | 193.23M |
| Short-term debt | 44.58M | 46.62M | 48.67M | 48.53M | 53.04M | 55.47M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 502,189,000.00 | 540,925,000.00 | 552,965,000.00 | 580,371,000.00 | 612,964,000.00 | 658,497,000.00 |
| Total equity | 726.17M | 750.71M | 769.01M | 779.66M | 809.97M | 841.28M |
| Retained earnings | -291.64M | -273.27M | -258.52M | -253.60M | -230.04M | -207.02M |
Cash flow
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 3.39M | 6.04M | 97.10M | 161.03M | 184.84M |
| Depreciation & amortization | 44.45M | 42.72M | 47.43M | 60.36M | 73.66M |
| Free cash flow | -52.92M | -98.12M | -41.71M | 52.90M | 26.14M |
| Dividends paid | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -553.00K | 37.00K | 343.96M | 5.49M | 5.00M |
| Ending cash balance | 140.33M | 39.13M | 332.43M | 366.12M | 282.92M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 38.58M | 60.32M | 45.64M | 40.30M | 64.07M | 70.46M |
| Depreciation & amortization | 20.81M | 16.82M | 17.63M | 18.41M | 25.47M | 20.97M |
| Free cash flow | 2.70M | 19.20M | 1.37M | 2.87M | 15.48M | 29.30M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 289.35M | 290.17M | 284.57M | 282.92M | 295.77M | 322.76M |
Returns & efficiency
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE %i | -- | -- | 21.72 | 20.58 | 8.64 |
| ROA %i | -10.32 | -12.47 | 1.69 | 12.10 | 5.04 |
| ROIC %i | -- | -- | 1.27 | 13.16 | 4.33 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- |
| EBIT margin %i | -6.49 | -10.43 | 4.31 | 6.32 | 6.73 |
| FCF / sales %i | -- | -- | -- | 5.49 | 2.22 |
| Current ratioi | 2.98 | 0.69 | 3.25 | 2.97 | 2.65 |
| Quick ratioi | 2.83 | 0.56 | 3.16 | 2.86 | 2.53 |
| Debt / assetsi | 4.24 | 53.90 | 34.17 | 32.38 | 34.28 |
| LT debt / equityi | -- | -- | 53.19 | 49.09 | 53.58 |
| Interest coveragei | -6.75 | -1,252.06 | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 24.44 | 27.88 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 21.73 | 20.90 | 19.84 | 8.64 | 8.02 | 8.32 |
| ROA %i | 12.72 | 12.07 | 11.45 | 5.04 | 4.65 | 4.75 |
| ROIC %i | 13.72 | 13.15 | 12.50 | 4.33 | 4.13 | 4.36 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.62 | 6.84 | 6.96 | 6.73 | 7.12 | 7.32 |
| FCF / sales %i | 4.91 | 4.37 | 2.24 | 2.22 | 3.03 | 3.57 |
| Current ratioi | 3.00 | 2.72 | 2.69 | 2.65 | 2.65 | 2.48 |
| Quick ratioi | 2.87 | 2.62 | 2.56 | 2.53 | 2.53 | 2.36 |
| Debt / assetsi | 33.58 | 33.59 | 33.54 | 34.28 | 35.03 | 34.72 |
| LT debt / equityi | 50.66 | 51.58 | 51.32 | 53.58 | 55.00 | 55.31 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- CAVA is the largest reported line at 99.18% of revenue, across 2 reported segments.
- The next-largest line, Other revenue, is a distant second at 0.82% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
CAVA99.18%
Other revenue0.82%
Quote time 2026-10-08 06:33:26 · For reference only, not investment advice and not tailored to your situation.